JP Patent

JP2009504775A — 糖尿病の治療法および体重の減少法

Assigned to Amylin Pharmaceuticals LLC · Expires 2009-02-05 · 17y expired

What this patent protects

エキセンディン、エキセンディン作動薬、またはエキセンディン類似体の作動薬を使用した、体重の減少、身体組成の変換、糖尿病の治療、HbA 1c の減少、および毎日の平均血糖の減少方法。【選択図】図３

USPTO Abstract

エキセンディン、エキセンディン作動薬、またはエキセンディン類似体の作動薬を使用した、体重の減少、身体組成の変換、糖尿病の治療、HbA 1c の減少、および毎日の平均血糖の減少方法。【選択図】図３

Drugs covered by this patent

Patent Metadata

Patent number: JP2009504775A
Jurisdiction: JP
Classification: —
Expires: 2009-02-05
Drug substance claim: No
Drug product claim: No
Assignee: Amylin Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.